Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
American Diabetes Association (ADA 2023)
REal-World Impact of Once-Weekly Injectable Semaglutide on GLycemic Control and Weight Outcomes in Type 2 DiAbeTEs (RELATE – OW Injectable Semaglutide)
American Diabetes Association (ADA 2023)